Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization

Completed 4 enrolled New Hope Fertility Center

Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of the study is to evaluate the safety and efficacy of nasal gonadotropins (Menopur) in women undergoing IVF. The purpose of this study is also to report and monitor any and all side effects of the nasal Menopur.

Timeline

Start: 2016-07-01
Primary completion: 2017-06-07
Completion: 2017-06-07

Publications

Results Zhang J, Merhi Z. Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment. JBRA Assist Reprod. 2019 Apr 30;23(2):169-171. doi: 10.5935/1518-0557.20180078.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Menopur	Protein / enzyme biologic	7.5 iu	Intranasal
Subject	Nafarelin	Other / unclassified	—	Intranasal
Comparator	hCG	Unknown	—	Other
Background	Clomiphene	Other / unclassified	—	Oral
Background	Letrozole	Other / unclassified	—	Oral

Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization

Summary

Timeline

Publications

Drugs

Indications